Come up with a name for your new list and we'll add to it:
Medicago raised a round of funding on September 18, 2013. Investors include
Mitsubishi Tanabe Pharma.
Medicago is committed to provide highly effective and affordable vaccines based on proprietary Virus-Like Particle (VLP) and manufacturing technologies. Medicago is developing VLP vaccines to protect …